ATC Group: D06BB13 Berdazimer sodium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D06BB13 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D06 Antibiotics and chemotherapeutics for dermatological use
3 D06B Chemotherapeutics for topical use
4 D06BB Antivirals
5 D06BB13

Active ingredients in D06BB13

Active Ingredient

Berdazimer is a nitric oxide releasing agent indicated for the topical treatment of molluscum contagiosum. The mechanism of action for the treatment of molluscum contagiosum is unknown.

Related product monographs

Document Type Information Source  
 ZELSUVMI Topical gel MPI, US: SPL/PLR FDA, National Drug Code (US)

United States medicines